Psychedelic Stocks Archives - Page 48 of 61

FridayJul 08, 2022 11:13 am

Study Suggests How Psychedelic Integration Can Be Measured

There has been increased interest in psychedelic treatments in recent years as initial studies have revealed that psychedelic drugs have the potential to alleviate certain mental health conditions. Psychedelic therapy is a relatively new field, but it has shown great promise in treating conditions such as mood disorders and post-traumatic stress disorder (PTSD). Now a study that was recently published in “Frontiers of Psychology” looks to give physicians a way to apply and measure psychedelic integration throughout the therapy process. Psychedelic integration refers to a process where a patient revisits their past traumatic experiences under the influence of psychedelics, pays…

ThursdayJul 07, 2022 12:59 pm

Federal Health Agencies Admit That Classification of Psychedelics Is Impeding Research

Several psychedelics are outlawed by federal law, with the United States classifying drugs such as psilocybin, LSD, MDMA, mescaline and peyote as Schedule I controlled substances with no accepted medical use. Even though a few states have loosened some of their psychedelic policies, federal law prohibits the production, sale and use of psychedelic drugs. According to two federal health agencies, federal prohibition has forced researchers to jump through numerous regulatory hoops and held back efforts to study the potential benefits and risks of psychedelic drugs. In a four-page letter sent as a response to Sen. Cory Booker’s and Sen. Brian…

WednesdayJul 06, 2022 2:42 pm

Archaeologists Believe Hidden Andean Passageways Were Most Likely Used During Psychedelic Rituals

In the past few years, archaeological studies have revealed that ancient people may have used recreational drugs in their rituals. According to archaeologists, ancient Andean civilizations may have used hidden passageways to take part in rituals that involved psychedelic drugs. Archaeologists on a dig in Peru discovered a network of hidden galleries and passageways deep inside an ancient temple complex called Chavin de Huántar, which is located in the Peruvian Andes. The archaeologists believe that this complex of passageways and chambers was used in religious rituals that may have involved psychedelic drugs. These hidden structures had been sealed off from…

TuesdayJul 05, 2022 2:03 pm

Canadian Company Seeks Permission to Produce Psychedelics Such as LSD, MDMA

A Canadian company based in Vancouver, Canada, is seeking permission from regulators to produce psychedelics such as LSD and MDMA at its British Columbia facility. Psychedelics have been seeing a resurgence in popularity in Canada, with the country’s national health policy agency moving to approve the restricted use of psychedelics for therapy early this year. Opitmi Health Corporation, a company that develops natural mushroom formulations, has asked federal regulators to allow it to manufacture synthetic psychedelic drugs at its facility in British Columbia. The Vancouver-based company has requested a controlled substances dealers license that would allow it to synthesize psychedelic…

FridayJul 01, 2022 11:11 am

Study Finds That DMT May Be Used to Effectively Treat Depression

Anyone who has used DMT (N, N-dimethyltryptamine) knows that it is a powerful hallucinogen that can induce immersive hallucinations in only a few minutes. The drug’s effects are similar to those of other psychedelics, including psilocybin mushrooms and LSD. Now that psychedelics are seeing a resurgence in popularity, researchers have been interested in how these drugs can impact mental health. According to a new study published in the “Nature” journal, DMT may have the potential to treat depression. The researchers’ objective was to see whether administering DMT would have any effect on patients with depressive symptoms. Researchers discovered that patients…

ThursdayJun 30, 2022 2:00 pm

Appeal Board Upholds Compass Pathways’ Patent on Synthetic Psilocybin Formulation

A psychedelics company recently scored a major win after the Patent Trial and Appeal Board (PTAB) upheld a novel psychedelic patent that was under challenge. Compass Pathways PLC (NASDAQ: CMPS), a mental healthcare company based in the United Kingdom, synthesized and patented a type of psilocybin called Comp 360. In late 2021, a nonprofit called Freedom to Operate issued a legal challenge against the patents, arguing that Comp 360, which is also known as Polymorph A, was not a new and unique invention. The nonprofit stated that the synthetic psilocybin existed in the public domain and was not a novel…

WednesdayJun 29, 2022 1:10 pm

NJ Senate President Introduces Psilocybin Legalization Bill Containing Home-Cultivation Provision

New Jersey’s senate president recently filed a bill that would legalize the home cultivation, possession and gifting of psilocybin or magic mushrooms to adults aged 21 and older. The psychedelic reform bill contains provisions that would grant the psychedelics market more freedoms than the cannabis market. Last February, New Jersey Governor Phil Murphy signed a bill that reclassified the possession of psilocybin mushrooms from a third-degree crime with a penalty of three to five years in jail and up to $15,000 in fines to a disorderly persons offense with a maximum fine of $1,000, up to six months’ jail time,…

TuesdayJun 28, 2022 1:55 pm

Psychedelics Voter Initiatives That May Qualify for Ballot in Colorado

Colorado residents may soon be able to vote on the decriminalization and regulation of psychedelics. If two voter initiatives centered around psychedelics qualify for the ballot, voters in Colorado could vote to decriminalize psychedelics during the November ballot. Initiative 58 and initiative 61 are currently in the signature-gathering stage, with each having to collect no less than 124,635 valid signatures by Aug. 8, 2022, to qualify for the ballot. Initiative 61, Legal Possession and Use of Entheogenic Plants and Fungi, would decriminalize the personal possession and use of specific entheogenic fungi and plants for adults aged 21 years and older.…

MondayJun 27, 2022 2:48 pm

What Investors Interested in Psychedelics Need to Focus on Regarding IP Issues

The psychedelics market is expected to record significant growth over the next decade as researchers uncover more ways psychedelics can be used to treat mental health conditions. With industry projections showing that psychedelics may even surpass the extremely lucrative cannabis industry, one question that remains in some stakeholders’ minds is how the psychedelic market will deal with IP issues as it grows. Psychedelics present a curious situation that makes a variety of the substances ineligible for patent protection. For example, while pharmaceutical companies that develop and synthesize chemical compounds in the lab are allowed to patent their drugs, psychedelics such…

FridayJun 24, 2022 2:48 pm

New Netflix Series to Explore the Use of Psychedelics for Mental Health

Over the last decade or so, a growing body of research has revealed a link between mental health and psychedelics. Researchers have found that psychedelic drugs such as LSD and psilocybin have the potential to alleviate mental health conditions, including depression and post-traumatic stress disorder (PTDS). Now a new documentary from Netflix seeks to teach viewers about some of the mental health outcomes associated with psychedelic use. The documentary is named after Michael Pollan’s book, titled “How to Change Your Mind,” which was originally published in 2018. It will be adapted into film by Academy Award-Winning documentary film director and…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks